Latest Articles

Publication Date
All News Scientific
Dramatic Spike in Molecular Testing for Endometrial Cancer Tells “Positive Story” - Oncology News Central

Dramatic Spike in Molecular Testing for Endometrial Cancer Tells “Positive Story” Oncology News Central

Published: Dec. 5, 2024, 12:54 p.m.
Read Full Article
Dramatic Spike in Molecular Testing for Endometrial Cancer Tells “Positive Story” - oncologynewscentral.com

Dramatic Spike in Molecular Testing for Endometrial Cancer Tells “Positive Story” oncologynewscentral.com

Published: Dec. 5, 2024, 12:54 p.m.
Read Full Article
Recommendations and Future Directions of Genetic Testing for CLL - Targeted Oncology

Recommendations and Future Directions of Genetic Testing for CLL Targeted Oncology

Published: Dec. 3, 2024, 1 a.m.
Read Full Article
3 FDA Approvals Signal Year of Change for Endometrial Cancer Care - Oncology News Central

3 FDA Approvals Signal Year of Change for Endometrial Cancer Care Oncology News Central

Published: Nov. 13, 2024, 11:41 a.m.
Read Full Article
3 FDA Approvals Signal Year of Change for Endometrial Cancer Care - oncologynewscentral.com

3 FDA Approvals Signal Year of Change for Endometrial Cancer Care oncologynewscentral.com

Published: Nov. 13, 2024, 11:41 a.m.
Read Full Article
Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium - The Manila Times

Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium The Manila Times

Published: Oct. 23, 2024, 10:06 a.m.
Read Full Article
The Targeted Pulse: Endometrial Cancer Scores Multiple FDA Approvals, T-DXd Shows Promise in Breast Cancer, and More - Targeted Oncology

The Targeted Pulse: Endometrial Cancer Scores Multiple FDA Approvals, T-DXd Shows Promise in Breast Cancer, and More Targeted Oncology

Published: June 23, 2024, 7 a.m.
Read Full Article
FDA Approves Durvalumab Combination for Advanced or Recurrent Endometrial Cancer - Oncology News Central

FDA Approves Durvalumab Combination for Advanced or Recurrent Endometrial Cancer Oncology News Central

Published: June 17, 2024, 7 a.m.
Read Full Article
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting - PR Newswire

Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting PR Newswire

Published: April 24, 2024, 7 a.m.
Read Full Article
Education Session to Discuss the Implementation of New Drugs in Gynecologic Oncology - ASCO Daily News

Education Session to Discuss the Implementation of New Drugs in Gynecologic Oncology ASCO Daily News

Published: April 24, 2024, 7 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!